Rigel Pharmaceuticals, Inc. · NASDAQ:RIGL
Frohlich Mark W received 5,750 Rigel Pharmaceuticals, Inc. shares as an award (Form 4)
Traded May 15, 2026 · Filed May 19, 2026
On May 15, 2026, Frohlich Mark W (Director) received 5,750 Rigel Pharmaceuticals, Inc. shares as an award, leaving 7,000 shares. Filed May 19, 2026 (Form 4).
- Awarded
- 5,750 shares
- Holding after
- 7,000 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 15, 2026 | Common Stock | Award | 5,750 | 7,000 | Direct |